Trial Profile
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Dasotraline (Primary)
- Indications Attention-deficit hyperactivity disorder; Bulimia nervosa
- Focus Pharmacokinetics
- Sponsors Sumitomo Pharma America
- 29 Nov 2016 Status changed from recruiting to completed.
- 14 Jun 2016 New trial record